Aristippos Gennadios, Group President Pharma & Consumer at Catalent, Inc. (CTLT), sold 281 shares at $47.87 ($13K) on 2023-08-01, disclosed to the SEC on 2023-08-03.
Seasonal sale ($13k) by Group President Pharma & Consumer — this insider has traded CTLT in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.58 | 61 | $3K | 21.2% |
| 2 | $47.87 | 220 | $11K | 78.8% |
| Total | $47.59 avg | 281 | $13K | 100% |
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |
| CTLT | SELL | 2022-07-28 | $43K | — | Filing → |